RxDoctor Payments Data

Octavia Cannon, DO

Obstetrics & Gynecology · East Lansing, MINPI 1497734701

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $19,313 of the $26,417 with a category attached, or 73.1%. Astellas Pharma US Inc accounts for 95.5% of it on its own, with 18 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,417in general payments, 2019–2025

Across 75 payments — averaging $352.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$25K
  • AbbVie$357
  • Lupin Inc.$117
  • Novo Nordisk$111
  • Sage Therapeutics, LLC$101
  • Exeltis, USA Inc.$76
  • plus $428 from 13 others

What the payments were for

  • Consulting fees$1,6746%
  • Speaking & faculty fees$19,31373%
  • Travel & lodging$3,54013%
  • Food & beverage$1,6746%
  • Education$2161%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,417 in reported general payments places this provider in the 95th percentile of 1,474 obstetrics & gynecology providers in Michigan.

See all obstetrics & gynecology providers in Michigan

Medicare billing

Part B allowed, 2024
$4,587
Medicare patients
29
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol43$8,023
Clobetasol Propionate24$430
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$82

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in East Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →